BioCentury
ARTICLE | Company News

UCB, Meizler deal

June 4, 2012 7:00 AM UTC

UCB will acquire a 51% stake in Meizler to establish a commercial presence in Brazil. UCB said it did not have a direct presence in the Brazilian market until now. The deal includes milestones and an option to purchase the remaining 49%. Meizler will be renamed Meizler UCB Biopharma S.A. Details were not disclosed. ...